| Dec 26, 2012
| 4:20 PM
The Baltimore VA Medical Center said Wednesday it has become the first hospital in Maryland to offer three-dimensional mammograms, a technology it hopes will better detect breast cancer in women.
Approved by the Food and Drug Administration last year, 3-...
| Sep 10, 2012
| 5:04 AM
It's a common refrain in Gia D'Anna's office: Extra inches that childbirth or time left around the middle are resisting diet and exercise.
D'Anna is the office manager for a Lutherville plastic surgeon, and, as a mother, she sympathizes with the...
| Aug 1, 2012
| 1:14 PM
NEW YORK (Reuters Health) - A new, small study found people with Parkinson's disease who took caffeine pills saw slight but noticeable improvements in movement problems related to the condition.
The findings warrant further study, Canadian researchers...
| Aug 8, 2012
| 1:52 PM
NEW YORK (Reuters Health) - The worse outcomes among people with cancer who live in poor neighborhoods don't seem to be because they live in areas with fewer doctors and hospitals, according to a new study.
Researchers found that poor neighborhoods in...
| Aug 25, 2012
-- It's worth noting that no exercises or diets specifically target belly fat—despite the promises of many infomercials. As Dr. Samuel Klein, professor of medicine and nutritional science at Washington University School of Medicine, explains, you...
| Sep 13, 2012
Until now, doctors have pretty much called the shots in the doctor-patient relationship. But change is on the way. Patients, say ahhhhh — it's about to be all about you.
The new approach is called patient-centered care, and it's a very good thing,...
| May 28, 2012
| 12:46 PM
Dr. Mark E. Molliver, a Johns Hopkins University School of Medicine professor emeritus of neuroscience and neurology, died of complications after cardiac arrest May 10 at Hopkins Hospital. The Canton resident was 75.
Colleagues said his discoveries had...
| Jun 25, 2012
| 8:32 AM
NEW YORK (Reuters Health) - Babies with life-threatening allergic reactions to milk or egg often don't get prompt treatment, despite their caretakers having been given medicine to counter the attacks, a new government-funded study shows.
| Jun 27, 2012
| 6:43 PM
The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
Once it is cleared by the Drug Enforcement...
| Jul 9, 2012
| 1:19 PM
NEW YORK (Reuters Health) - Many heart patients get newer, pricey stents inserted during artery-clearing procedures, even if it's not clear they'd be worse off with more basic models, a new study suggests.
Along with being more costly, so-called drug-...
| Jul 11, 2012
| 1:37 PM
NEW YORK (Reuters Health) - Although most people who participated in a new survey preferred making medical decisions together with their doctor, the majority said they wouldn't speak up if what they wanted conflicted with their physician's...